Introduction
============

Saliva is a biological fluid composed of more than 99% water and less than 1% protein, electrolytes and other low-molecular-weight components. It originates mainly from three pairs of major salivary glands (parotid, submandibular and sublingual glands), as well as from 300 to 400 minor salivary glands present in the oral cavity. Saliva plays a key role in lubrication, chewing, swallowing and digestion. It protects the oral tissues and also provides biomarkers for local and systemic diseases[@B17]. Therefore, saliva contains more than 2000 proteins and peptides that are involved in an infinity of different biological functions in the oral cavity[@B17]. Saliva still plays a large role in the formation of acquired pellicle, which begins only a few seconds after exposure of the enamel to saliva[@B5].

Human saliva is a biological fluid with enormous diagnostic potential. Because saliva can be noninvasively collected, it provides an attractive alternative for blood, serum or plasma[@B13].

In the human saliva were identified 1166 proteins, and high portions of these proteins were found in serum. Currently, progress in salivary diagnostics has demonstrated that these contents can be very informative for detection of oral and systematic diseases[@B20].

Proteomics, a new field of research centered on identification, quantitation, and characterization of proteins and their interplay, is largely based on the robustness, sensitivity, speed, and throughput of mass spectrometric procedures[@B6]. Currently, mass spectrometry is the basic technology for large-scale identification of these salivary proteins, and proteomic analysis of saliva has distinct advantages over blood, especially for proteins of low abundance[@B17] ^,^ [@B18]. One of the main challenges in proteomic analysis is the fact that highly abundant proteins can impair the identification of low-abundance proteins, considering the equipment dynamic range. In the case of saliva, albumin and immunoglobulin G (IgG), they are very abundant, and some authors have recommended using columns for depletion of these proteins during the extraction procedure[@B7] ^,^ [@B8]. Saliva functions are not only restricted to process food for digestion, considering that it contains a large number of proteins, which play important roles in the regulation of the immune defense and endocrine system and in the maintenance of mucosal tissue and dental health[@B1].

Saliva may contain locally expressed proteins and other substances called biomarkers, which can be used as diseases\' indicators, be closely related to an individual\'s health condition and change greatly when diseases occur. In general, most studies view saliva wrongly as a homogeneous body fluid. It is also not stable, but constantly in change, and its composition is affected among other things by sampling methodology, environment, periodicity, oral hygiene, psychological status and general health[@B6] ^,^ [@B13] ^,^ [@B20].

Considering the importance of saliva in the oral cavity homeostasis, as well as its great potential as a diagnostic fluid, the aim of this study was to standardize a protocol to extract salivary proteins for further proteomic analysis. In the first test, we evaluated the need for using an albumin and IgG column to deplete these proteins during protein extraction. In the second test, we compared analysis of samples pooled from 10 volunteers with samples from individual analysis.

Material and methods
====================

Ethical aspects and human subjects
----------------------------------

The protocol of this study was submitted and approved by the Ethics Committee in Research with Human Beings of the Bauru School of Dentistry - FOB/USP (CAAE No. 61484116.0.0000.5417). Ten participants with good general and oral health took part of this study, which was based on previous *in vivo* studies[@B18]. Inclusion criteria were: nonsmokers with good general and oral health, stimulated salivary flow \>1 mL/min and unstimulated salivary flow \>0.25 mL/min, salivary pH\>6.0.

Saliva collection
-----------------

The volunteers were asked to rest for 15 min before collecting saliva, sitting upright. They were asked not to speak or eat before beginning to collect saliva. First, they rinsed their mouths with 5 mL of drinking deionized water, then they were asked to swallow saliva for 5 min. After this period, the volunteers spit out all the saliva accumulated in the mouth in a plastic tube immersed in ice for 10 min (unstimulated flow). The saliva samples were immediately centrifuged at 14,000 g for 15 min at 4°C to remove all debris, such as insoluble material, cell debris and food debris. The supernatant from each sample was collected and frozen at -80°C until analysis. These procedures were based on previous studies[@B6] ^,^ [@B18].

Preparation of the saliva samples
---------------------------------

The experiments were performed into two phases. The first test was done to evaluate whether or not the albumin & IgG Depletion SpinTrap column (GE Healthcare^®^, Buckinghamshire, UK) should be used. The second test was performed after the results of the first to compare analysis of salivary samples pooled from all the 10 volunteers with analysis of an individual sample from one selected volunteer.

For the first test, 100 μl of saliva from each volunteer was taken and transferred to 10 new tubes. For the second test, 100 μl of each saliva sample was also taken and transferred to 10 new tubes to constitute the pool, while 1 ml of saliva was taken from only one of the volunteers (randomly selected) for individual analysis.

Proteins from the saliva samples were extracted using an equal volume of a solution containing 6 M urea, 2 thiourea in 50 mM NH~4~HCO~3~ pH 7.8. The samples were vortexed at 4°C for 10 min, sonicated for 5 min and centrifuged at 14,000 g at 4°C for 10 min. This step was repeated once more. For the first test (with or without the use of the albumin and IgG depletion column), we added 100 μl of the extraction solution to each Eppendorf tube. For the second test (pool X individual analysis), we added 100 µl of the extraction solution in each Eppendorf tube (for the samples that will be pooled later on), while for the individual sample, we added 1 ml of the extraction solution. In all the cases, an equal volume of saliva sample and extraction solution was used. For the pooled samples, we placed the content of the 10 tubes in one tube after the extraction procedure, constituting the pool for further analysis.

After extraction, for the first test, the pooled sample was loaded into the albumin & IgG depletion columns, according to the manufacturer´s instructions Albumin & IgG Depletion SpinTrap column (GE Healthcare^®^, Buckinghamshire, UK). We did not use this column in the second test.

The samples were then concentrated to 150 μl in Falcon Amicon tubes (Merck Millipore^®^, Tullagreen, County Cork, Ireland). After concentration, the samples were reduced with 5 mM dithiothreitol (DTT) for 40 min at 37°C, alkylated with 10 mM iodoacetamide (IAA) for 30 min in the dark. After this procedure, we added 100 μl of 50 mM NH~4~HCO~3~, and the samples were digested with 2% (w/w) trypsin (Promega^®^, Madison, USA) for 14 hours at 37°C. After this period, we added 10 µl of 5% formic acid to stop the trypsin reaction, then the samples were purified and desalted using the C18 Spin columns (Thermo Scientific^®^, Rockford, Illinois, USA) and we withdrew a 1 ul aliquot of each sample from the tests for protein quantification by the Bradford method (Bio-Rad^®^, Hercules, Califórnia, USA)[@B16]. We resuspended the samples in the solution containing 3% acetonitrile and 0.1% formic acid to be submitted to Nano Liquid Chromatography Electron Spray Ionization Tandem Mass Spectrometry - LC-ESI-MS/MS (Waters, Manchester, New Hampshire, UK).

Shotgun label-free quantitative proteomic analysis
--------------------------------------------------

Peptides identification was performed on a nanoACQUITY UPLC-Xevo QTof MS system (Waters, Manchester, New Hampshire, UK). The nanoACQUITY UPLC was equipped with nanoACQUITY HSS T3, analytical reverse phase column (75 μm X 150 mm, 1.8 μm particle size (Waters, Manchester, New Hampshire, UK). The column was equilibrated with mobile phase A (0.1% formic acid in water). Then, the peptides were separated with a linear gradient of 7-85% mobile phase B (0.1% formic acid in ACN) for 70 min at a flow rate of 0.35 μL/min. The column temperature was maintained at 55°C. The Xevo G2 Q-TOF mass spectrometer was operated in positive nano-electrospray ion mode, and data were collected using the MSE method in elevated energy (19-45 V), which allows data acquisition of both precursor and fragment ions, in one injection. Source conditions used included capillary voltage, 2.5 kV; sample cone, 30 V; extraction cone, 5.0 V and source temperature, 80^0^C. Data acquisition occurred over 70 min, and the scan range was 50--2000 Da. The lockspray, used to ensure accuracy and reproducibility, was run with a \[Glu1\] fibrinopeptide solution (1 pmol/μL) at a flow rate of 1 μL/min, as a reference ion in positive mode at m/z 785.8427. ProteinLynx Global Server (PLGS) version 3.0 was used to process and search the LC-MSE continuum data. Proteins were identified with the embedded ion accounting algorithm in the software and a search of the Homo sapiens database (reviewed only, UniProtKB/Swiss-Prot) downloaded on September 2015 from UniProtKB (http://www.uniprot.org/). The use of human database excludes the identification of bacterial proteins that could be present in the saliva.

Results
=======

In the first test, when the albumin and IgG depletion column was used, the total amount of protein recovered from the pooled samples after extraction was 8 μg, while only 35 salivary proteins were identified. Among them are proteins typically found in saliva, such as alpha-amylase 1 and 2B, cystatin isoforms, hemoglobin isoforms and mucin 7, among others ([Table 1](#t1){ref-type="table"}). When the depletion column was not used, the amount of protein recovered was much higher (48.0 μg) and 248 proteins were identified, among them many typical components of saliva such as alpha-amylase 1 and 2B, many cystatin isoforms, carbonic anhydrase 6, lactotransferrin, lysozyme C, mucin 7, proline-rich protein 4, protein S100A9, serotransferrin, statherin, several hemoglobin isoforms, among others ([Table 2](#t2){ref-type="table"}).

Table 1Salivary proteins identified when the albumin and IgG depletion column was usedAccession numberProtein namescoreCover (%)P04745Alpha-amylase 17589.7054.99P19961Alpha-amylase 2B6833.2047.75P04280Basic salivary proline-rich protein 1488.1443.88P02812Basic salivary proline-rich protein 23642.4445.67P49407Beta-arrestin-1158.669.09P01036Cystatin-S1465.1131.91P09228Cystatin-AS516.5924.11P01037Cystatin-SN1378.1921.28Q9UGM3Deleted in malignant brain tumors 1 protein98.932.11P14867Gamma-aminobutyric acid receptor subunit alpha-192.537.46G3V1N2HCG1745306\_ isoform CRA_a456.2022.73P69905Hemoglobin subunit alpha1306.8728.17P68871Hemoglobin subunit beta1659.6666.67P02042Hemoglobin subunit delta497.8425.17A0A0G2JMB2Ig alpha-2 chain C region (Fragment)559.9416.76P01876Immunoglobulin heavy constant alpha 1912.8230.59P01877Immunoglobulin heavy constant alpha 2345.3020.00P01591Immunoglobulin J chain1363.6336.48P01834Immunoglobulin kappa constant333.7151.40P0CG04Immunoglobulin lambda constant 1136.4014.15P0DOY2Immunoglobulin lambda constant 2165.4623.58P0DOY3Immunoglobulin lambda constant 3153.7423.58P0CF74Immunoglobulin lambda constant 6136.4014.15B9A064Immunoglobulin lambda-like polypeptide 5136.407.01P31025Lipocalin-11181.0126.70Q8TAX7Mucin-795.213.71P04746Pancreatic alpha-amylase6723.9941.49P01833Polymeric immunoglobulin receptor305.1515.58P12273Prolactin-inducible protein1027.8040.41A0A0A0MT31Proline-rich protein 48108.7672.29Q5VSP4Putative lipocalin 1-like protein 1958.486.79P02810Salivary acidic proline-rich phosphoprotein 1/28108.7672.29P02814Submaxillary gland androgen-regulated protein 3B2090.4865.82A0A087WZY1Uncharacterized protein7158.0816.60Q96DA0Zymogen granule protein 16 homolog B721.7041.83[^1]

Table 2Salivary proteins identified when the albumin and IgG depletion column was not usedAccession numberProtein namescoreCover (%)Q15118\[Pyruvate dehydrogenase (acetyl-transferring)\] kinase isozyme 1\_ mitochondrial89.508.26P3194614-3-3 protein beta/alpha166.373.25P6225814-3-3 protein epsilon177.853.14Q0491714-3-3 protein eta166.373.25P6198114-3-3 protein gamma166.373.24P3194714-3-3 protein sigma166.373.23P2734814-3-3 protein theta195.2312.65P6310414-3-3 protein zeta/delta166.373.27Q6ZVK88-oxo-dGDP phosphatase NUDT18138.1119.50E5KP25A/G-specific adenine DNA glycosylase242.245.28P68032Actin\_ alpha cardiac muscle 110751.1840.05P68133Actin\_ alpha skeletal muscle10681.8733.95P62736Actin\_ aortic smooth muscle10396.4837.14P60709Actin\_ cytoplasmic 118715.0266.67P63261Actin\_ cytoplasmic 218715.0266.67P63267Actin\_ gamma-enteric smooth muscle10327.1731.12Q6P461Acyl-coenzyme A synthetase ACSM6\_ mitochondrial399.1613.33Q9UIF7Adenine DNA glycosylase242.245.31Q9Y6U3Adseverin51.665.17C9JKR2Albumin\_ isoform CRA_k25004.4777.94P02763Alpha-1-acid glycoprotein 1259.497.46P01009Alpha-1-antitrypsin114.1714.59P01023Alpha-2-macroglobulin195.3714.25P04745Alpha-amylase 1125762.377.69P19961Alpha-amylase 2B85518.5567.91Q69YU3Ankyrin repeat domain-containing protein 34A213.8023.19Q5T3N1Annexin (Fragment)419.0334.31P04083Annexin A1454.2833.53P03973Antileukoproteinase822.9640.15Q16671Anti-Muellerian hormone type-2 receptor646.3018.32P02647Apolipoprotein A-I436.6832.58B1APP8ATP-dependent 6-phosphofructokinase\_ platelet type156.7221.29O14965Aurora kinase A187.178.93P04280Basic salivary proline-rich protein 113742.7344.39P02812Basic salivary proline-rich protein 236329.2469.23Q6W2J9BCL-6 corepressor171.502.34P61769Beta-2-microglobulin7681.8754.62Q562R1Beta-actin-like protein 21631.5817.02Q96DR5BPI fold-containing family A member 24054.4640.56Q8TDL5BPI fold-containing family B member 1238.4227.27Q8N4F0BPI fold-containing family B member 24941.7132.97Q8N4G4CA6 protein236.854.47P23280Carbonic anhydrase 61927.3343.83P07339Cathepsin D153.0517.96H0YDT2Cathepsin W (Fragment)152.4512.32A0A087X2B6Cell cycle and apoptosis regulator protein 2186.2213.60O60308Centrosomal protein of 104 kDa36.503.35O94986Centrosomal protein of 152 kDa24.185.03O75153Clustered mitochondria protein homolog864.269.93P35606Coatomer subunit beta\'186.056.73G3V1A4Cofilin 1 (Non-muscle)\_ isoform CRA_a613.6518.79P23528Cofilin-1613.6516.87Q8TD31Coiled-coil alpha-helical rod protein 147.652.43Q9P0B6Coiled-coil domain-containing protein 167170.3215.46P01024Complement C3181.969.32Q2VPA4Complement component receptor 1-like protein148.597.21P04080Cystatin-B3144.0655.10P01034Cystatin-C1547.1231.51P28325Cystatin-D535.3747.89P01036Cystatin-S41046.8373.76P09228Cystatin-SA21107.6153.90P01037Cystatin-SN40764.2468.09P54108Cysteine-rich secretory protein 3371.4526.94Q9UGM3Deleted in malignant brain tumors 1 protein274.046.80Q8IYB7DIS3-like exonuclease 2192.965.42Q9NVU0DNA-directed RNA polymerase III subunit RPC5187.744.66Q1HG43Dual oxidase maturation factor 1248.8913.12O95714E3 ubiquitin-protein ligase HERC2190.345.05Q8NG27E3 ubiquitin-protein ligase Praja-1680.8314.31P43897Elongation factor Ts\_ mitochondrial129.029.23Q0PNE2Elongator complex protein 663.6413.53V9HW75Epididymis secretory protein Li 109337.3322.86P02675Fibrinogen beta chain420.7740.73P02679Fibrinogen gamma chain453.8222.52Q0PRL4Forkhead box P2 variant 3142.4910.19Q8N6B5Forkhead box P2\_ isoform CRA_d (Fragment)142.4911.84O15409Forkhead box protein P2199.6512.45O95872G patch domain and ankyrin repeat-containing protein 1268.3217.70P19526Galactoside 2-alpha-L-fucosyltransferase 1174.7013.42P48058Glutamate receptor 450.222.55P04406Glyceraldehyde-3-phosphate dehydrogenase190.9016.72P00738Haptoglobin349.2124.88G3V1N2HCG1745306\_ isoform CRA_a22783.5758.18P69905Hemoglobin subunit alpha27452.8659.15P68871Hemoglobin subunit beta49667.2695.24P02042Hemoglobin subunit delta9498.6033.33P02100Hemoglobin subunit epsilon1940.466.80P69891Hemoglobin subunit gamma-11940.466.80P69892Hemoglobin subunit gamma-21940.466.80P02790Hemopexin460.9622.51P15515Histatin-132092.2536.84P15516Histatin-37558.2513.73P57058Hormonally up-regulated neu tumor-associated kinase218.103.50Q9BS19HPX protein352.1021.65A0A0G2JMB2Ig alpha-2 chain C region (Fragment)22147.5368.24A0A0A0MS07Ig gamma-1 chain C region (Fragment)1490.6645.76A0A087WYJ9Ig mu chain C region2129.9140.71P04220Ig mu heavy chain disease protein1800.8831.97P01876Immunoglobulin heavy constant alpha 125196.4361.19P01877Immunoglobulin heavy constant alpha 218459.8264.12P01857Immunoglobulin heavy constant gamma 13671.2850.91P01859Immunoglobulin heavy constant gamma 2729.3538.34P01860Immunoglobulin heavy constant gamma 3487.8124.93P01861Immunoglobulin heavy constant gamma 4599.4720.18P01871Immunoglobulin heavy constant mu2171.7247.68A0A075B7F0Immunoglobulin heavy variable 3/OR16-10 (non-functional) (Fragment)378.419.48S4R460Immunoglobulin heavy variable 3/OR16-9 (non-functional)5403.2831.25P01762Immunoglobulin heavy variable 3-11378.419.40P01766Immunoglobulin heavy variable 3-13378.419.48A0A0C4DH32Immunoglobulin heavy variable 3-20 (Fragment)378.419.40A0A0B4J1V1Immunoglobulin heavy variable 3-21378.419.40A0A0B4J1X8Immunoglobulin heavy variable 3-43378.419.32P01763Immunoglobulin heavy variable 3-48378.419.40P01780Immunoglobulin heavy variable 3-7401.3017.09P01782Immunoglobulin heavy variable 3-9378.419.32P01591Immunoglobulin J chain18415.2842.14P01834Immunoglobulin kappa constant16816.8385.98P0CG04Immunoglobulin lambda constant 19338.4577.36P0DOY2Immunoglobulin lambda constant 213921.1477.36P0DOY3Immunoglobulin lambda constant 313921.1477.36P0CF74Immunoglobulin lambda constant 613267.0450.94A0M8Q6Immunoglobulin lambda constant 710499.8936.79B9A064Immunoglobulin lambda-like polypeptide 59338.4538.32P08069Insulin-like growth factor 1 receptor32.755.63P06870Kallikrein-1227.7110.31Q9Y5K2Kallikrein-4304.5617.72P13645Keratin\_ type I cytoskeletal 10297.802.05Q99456Keratin\_ type I cytoskeletal 12421.1814.17P13646Keratin\_ type I cytoskeletal 134810.3346.94P02533Keratin\_ type I cytoskeletal 14158.424.24P19012Keratin\_ type I cytoskeletal 151164.8614.25P08779Keratin\_ type I cytoskeletal 16158.424.23Q04695Keratin\_ type I cytoskeletal 17143.472.08P08727Keratin\_ type I cytoskeletal 19529.846.75P35908Keratin\_ type II cytoskeletal 2 epidermal300.2522.07Q01546Keratin\_ type II cytoskeletal 2 oral165.1412.07P19013Keratin\_ type II cytoskeletal 4876.7142.13P13647Keratin\_ type II cytoskeletal 5489.997.97P02538Keratin\_ type II cytoskeletal 6A794.7831.56P04259Keratin\_ type II cytoskeletal 6B765.8828.01P48668Keratin\_ type II cytoskeletal 6C765.8828.01O95678Keratin\_ type II cytoskeletal 75190.383.81Q5XKE5Keratin\_ type II cytoskeletal 79190.383.93O14777Kinetochore protein NDC80 homolog410.899.03P22079Lactoperoxidase1724.3234.13P02788Lactotransferrin382.6532.11Q9C099Leucine-rich repeat and coiled-coil domain-containing protein 1270.779.98Q9NPC1Leukotriene B4 receptor 2209.154.37P31025Lipocalin-119334.3857.95P28330Long-chain specific acyl-CoA dehydrogenase\_ mitochondrial137.449.07Q8IYD9Lung adenoma susceptibility protein 2141.099.14P61626Lysozyme C10190.7570.27Q14680Maternal embryonic leucine zipper kinase208.248.14P42679Megakaryocyte-associated tyrosine-protein kinase156.3910.85P01033Metalloproteinase inhibitor 1858.6144.44Q2QL34Mpv17-like protein240.7311.73Q8TAX7Mucin-711686.2015.65Q8NCY6Myb/SANT-like DNA-binding domain-containing protein 4176.8111.30P24158Myeloblastin175.854.69Q8NCE2Myotubularin-related protein 14342.1619.38Q9NYA4Myotubularin-related protein 4234.5715.82F8WCT3NEDD8-conjugating enzyme UBE2F167.9837.18P59665Neutrophil defensin 11037.4617.02P59666Neutrophil defensin 31037.4617.02O00221NF-kappa-B inhibitor epsilon176.166.80Q2L696Nucb2 splice variant337.3324.62Q14980Nuclear mitotic apparatus protein 1278.084.96Q9Y618Nuclear receptor corepressor 244.623.33A0A087WSV8Nucleobindin 2\_ isoform CRA_b337.3322.86P80303Nucleobindin-2337.3322.86O75414Nucleoside diphosphate kinase 6140.7214.52C9JQB1Nucleoside diphosphate kinase140.7219.15Q9GZK3Olfactory receptor 2B2166.4919.33Q5SZR7Ornithine decarboxylase antizyme 3300.9518.55Q7RTY7Ovochymase-1190.5910.05P04746Pancreatic alpha-amylase79860.7959.10P13796Plastin-2364.9018.02P13797Plastin-3259.134.29P01833Polymeric immunoglobulin receptor10715.7741.62Q6S8J3POTE ankyrin domain family member E7556.2711.07A5A3E0POTE ankyrin domain family member F7557.1113.67P0CG38POTE ankyrin domain family member I6915.246.79P0CG39POTE ankyrin domain family member J2868.605.97P51531Probable global transcription activator SNF2L2158.852.01Q53EL6Programmed cell death protein 4138.408.74P12273Prolactin-inducible protein31682.1076.71Q16378Proline-rich protein 4312.6021.64H0Y4B9Propionyl-CoA carboxylase alpha chain\_ mitochondrial (Fragment)231.3120.90P07602Prosaposin205.849.35D6RDZ2Protein FAM193B (Fragment)266.8635.56Q14320Protein FAM50A176.5510.62Q5VT40Protein FAM78B141.8010.73Q8N7I0Protein GVQW1164.9117.95Q6P5S2Protein LEG1 homolog1162.2429.09Q8ND56Protein LSM14 homolog A270.509.50Q8WYL5Protein phosphatase Slingshot homolog 1322.723.91Q5THK1Protein PRR14L367.7410.13P06702Protein S100-A9571.6539.47Q96EA4Protein Spindly138.752.64Q58EX7Puratrophin-1166.932.60Q9BYX7Putative beta-actin-like protein 31002.9210.67Q5VSP4Putative lipocalin 1-like protein 13906.1711.11A8K554Putative protein ZNF815163.6726.15Q96GD0Pyridoxal phosphate phosphatase92.6211.15H3BR70Pyruvate kinase336.6018.03P14618Pyruvate kinase PKM336.6012.43Q15276Rab GTPase-binding effector protein 1349.018.24H3BPI9Receptor protein serine/threonine kinase (Fragment)641.7147.67P02810Salivary acidic proline-rich phosphoprotein 1/240463.0326.51Q14674Separin32.804.39Q9BZL6Serine/threonine-protein kinase D2165.213.87B4DTS2Serine/threonine-protein kinase165.213.83J3QLP4Serine/threonine-protein kinase RIO3 (Fragment)335.0350.56G3V5U8Serine/threonine-protein phosphatase 2A regulatory subunit B\'\' subunit gamma157.8124.53P02787Serotransferrin5631.5544.41P02768Serum albumin65771.6281.28P40763Signal transducer and activator of transcription 343.206.10Q9UBC9Small proline-rich protein 3424.0165.09A1L4H1Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D62.362.67P02808Statherin52769.2853.23P02814Submaxillary gland androgen-regulated protein 3B52053.0565.82Q9UMS6Synaptopodin-2184.001.83G5E9B5TCF3 (E2A) fusion partner (In childhood Leukemia)\_ isoform CRA_b165.6119.67Q8WW35Tctex1 domain-containing protein 2188.6914.08Q7Z6L1Tectonin beta-propeller repeat-containing protein 1350.1112.62Q9UKR8Tetraspanin-16313.9727.35P20061Transcobalamin-1230.3820.32A6H8Y1Transcription factor TFIIIB component B\'\' homolog167.292.82O95359Transforming acidic coiled-coil-containing protein 2372.276.41P55072Transitional endoplasmic reticulum ATPase236.0310.92P29401Transketolase133.4013.80Q8NDV7Trinucleotide repeat-containing gene 6A protein180.443.98K7EQY5Tyrosine-protein kinase156.3910.87Q86TW2Uncharacterized aarF domain-containing protein kinase 1174.7610.57H3BMD7Uncharacterized protein (Fragment)240.7319.49A0A087WZK3Uncharacterized protein (Fragment)469.2443.09A0A087WZY1Uncharacterized protein40463.0316.60A0A087WUV0Uncharacterized protein464.858.62E7ESA3Uncharacterized protein188.6918.87Q9HB07UPF0160 protein MYG1\_ mitochondrial435.4612.23Q9NY84Vascular non-inflammatory molecule 3540.7110.58Q14508WAP four-disulfide core domain protein 21637.9933.87E9PDB0WD repeat-containing protein 49424.405.02Q86UP3Zinc finger homeobox protein 4205.123.06Q5FWF6Zinc finger protein 789138.529.41Q17R98Zinc finger protein 827296.412.87P25311Zinc-alpha-2-glycoprotein5026.1755.03Q96DA0Zymogen granule protein 16 homolog B47333.9356.73

In the second test, for comparison of analysis of pooled *versus* individual sample, the depletion column was not used. For the pooled sample, the amount of protein recovered after extraction was 54.02 µg, which allowed the identification of 212 proteins, including alpha-amylase 1 and 2B, carbonic anhydrase 6, cystatin isoforms (B, C, D, S, SA, SN), histatin 1 and 3, lysozyme C, mucin 7, protein S100A8 and S100A9, statherin, several hemoglobin isoforms, among others ([Table 3](#t3){ref-type="table"}). In the analysis of the individual sample, 25.13 μg of total protein were obtained and 239 proteins were identified, among which are alpha-amylase 1 and 2B, alpha-enolase, carbonic anhydrase 6, many cystatin isoforms (B, C-D, S, SA, SN), histatin 1 and 3, Ig alpha-2 chain C region, Ig a chain C region, lactotransferrin, lysozyme C, mucin 7, protein S1008 and S100A9, serotransferrin, statherin, among other proteins ([Table 4](#t4){ref-type="table"}).

Table 3Proteins of the saliva identified in the pool analysisAccession numberProtein namescoreCover(%)P168851-phosphatidylinositol 4_5-bisphosphate phosphodiesterase gamma-2314.784.51P68032Actin\_ alpha cardiac muscle 16085.3131.30P68133Actin\_ alpha skeletal muscle6085.3131.30P62736Actin\_ aortic smooth muscle4676.9428.38P60709Actin\_ cytoplasmic 11749667.20P63261Actin\_ cytoplasmic 21749667.20P63267Actin\_ gamma-enteric smooth muscle4676.9428.46Q01518Adenylyl cyclase-associated protein 1440.2726.11C9JKR2Albumin\_ isoform CRA_k26466.7274.82P01009Alpha-1-antitrypsin2252.6022.97P01023Alpha-2-macroglobulin665.7022.86P04745Alpha-amylase 1153591.9078.86P19961Alpha-amylase 2B110753.5058.51P06733Alpha-enolase1637.7633.87Q01484Ankyrin-252.622.75P03973Antileukoproteinase701.5328.03P63010AP-2 complex subunit beta338.392.35P02647Apolipoprotein A-I612.3139.70P02652Apolipoprotein A-II886.7869.00Q5FYB0Arylsulfatase J389.1810.35Q8IYB8ATP-dependent RNA helicase SUPV3L1\_ mitochondrial235.176.23P04280Basic salivary proline-rich protein 13925.2058.67P02812Basic salivary proline-rich protein 273554.9769.47P61769Beta-2-microglobulin3725.1748.74Q562R1Beta-actin-like protein 21532.8313.30P13929Beta-enolase264.7813.36Q96DR5BPI fold-containing family A member 24561.1858.23Q8N4F0BPI fold-containing family B member 26508.7530.79A0A087WXK1BRCA1-A complex subunit Abraxas (Fragment)332.7716.93Q8N4G4CA6 protein419.284.47O75638Cancer/testis antigen 2716.3919.05P23280Carbonic anhydrase 615792.2162.01P00450Ceruloplasmin71.048.45E9PM92Chromosome 11 open reading frame 58258.6915.29P01024Complement C3833.4221.17P51160Cone cGMP-specific 3\'\_5\'-cyclic phosphodiesterase subunit alpha\'232.1411.07H3BRY3Coronin502.1022.11P31146Coronin-1A502.1024.95Q92772Cyclin-dependent kinase-like 2457.9711.97P04080Cystatin-B2288.2745.92P01034Cystatin-C3131.8551.37P28325Cystatin-D3348.3261.97P01036Cystatin-S34860.6673.76P09228Cystatin-SA24277.6967.38P01037Cystatin-SN23133.2370.21P54108Cysteine-rich secretory protein 3284.3821.63P32320Cytidine deaminase1245.0866.44Q9UGM3Deleted in malignant brain tumors 1 protein306.824.97Q13609Deoxyribonuclease gamma411.3715.74A0A0A0MT68Deoxyribonuclease411.3716.67P27487Dipeptidyl peptidase 473.314.83O60216Double-strand-break repair protein rad21 homolog322.9519.02R4GN68Dual-specificity mitogen-activated protein kinase kinase 4780.1697.56V9HW75Epididymis secretory protein Li 109954.6725.48B1AK53Espin277.284.80Q01469Fatty acid-binding protein\_ epidermal475.7630.37Q8NCQ5F-box only protein 15465.733.73P02679Fibrinogen gamma chain372.1721.63Q08380Galectin-3-binding protein237.9618.97P06744Glucose-6-phosphate isomerase222.1422.04E7ETY7Glutathione peroxidase341.4222.78P09211Glutathione S-transferase P519.2925.71P04406Glyceraldehyde-3-phosphate dehydrogenase407.3911.64Q8IWJ2GRIP and coiled-coil domain-containing protein 2718.244.81P00738Haptoglobin960.3241.87G3V1N2HCG1745306\_ isoform CRA_a11936.3357.27P69905Hemoglobin subunit alpha13598.4254.93P68871Hemoglobin subunit beta18402.5489.80P02042Hemoglobin subunit delta5838.8963.95P02100Hemoglobin subunit epsilon3895.006.80P69891Hemoglobin subunit gamma-13895.006.80P69892Hemoglobin subunit gamma-23895.006.80P15515Histatin-116204.5436.84P15516Histatin-32631.5013.73Q16695Histone H3.1t524.0623.53Q05469Hormone-sensitive lipase43.685.30Q4G0P3Hydrocephalus-inducing protein homolog15.211.93A0A0G2JMB2Ig alpha-2 chain C region (Fragment)43004.2979.12A0A0A0MS07Ig gamma-1 chain C region (Fragment)2528.8042.37A0A087WYJ9Ig mu chain C region4012.8548.67P04220Ig mu heavy chain disease protein3190.6437.85P01876Immunoglobulin heavy constant alpha 138140.4673.65P01877Immunoglobulin heavy constant alpha 232255.8465.29P01857Immunoglobulin heavy constant gamma 14336.0647.88P01859Immunoglobulin heavy constant gamma 21181.1737.42P01860Immunoglobulin heavy constant gamma 31276.1414.59P01861Immunoglobulin heavy constant gamma 41489.8438.23P01871Immunoglobulin heavy constant mu4017.9950.33A0A075B7F0Immunoglobulin heavy variable 3/OR16-10 (non-functional) (Fragment)299.809.48A0A075B7B8Immunoglobulin heavy variable 3/OR16-12 (non-functional) (Fragment)242.499.40A0A075B7E8Immunoglobulin heavy variable 3/OR16-13 (non-functional) (Fragment)242.499.40S4R460Immunoglobulin heavy variable 3/OR16-9 (non-functional)5489.7131.25P01762Immunoglobulin heavy variable 3-11299.809.40P01766Immunoglobulin heavy variable 3-13299.809.48A0A0C4DH32Immunoglobulin heavy variable 3-20 (Fragment)299.809.40A0A0B4J1V1Immunoglobulin heavy variable 3-21299.809.40P01764Immunoglobulin heavy variable 3-23242.4912.82P01768Immunoglobulin heavy variable 3-30242.4931.62P01772Immunoglobulin heavy variable 3-33242.4931.62A0A0B4J1X8Immunoglobulin heavy variable 3-43299.809.32P01763Immunoglobulin heavy variable 3-48299.809.40P01767Immunoglobulin heavy variable 3-53242.4912.93A0A0C4DH42Immunoglobulin heavy variable 3-66242.4912.93P01780Immunoglobulin heavy variable 3-7299.809.40A0A0B4J1X5Immunoglobulin heavy variable 3-74242.499.40P01782Immunoglobulin heavy variable 3-9299.809.32P01591Immunoglobulin J chain20006.9649.06P01834Immunoglobulin kappa constant28856.8882.24A0A0C4DH90Immunoglobulin kappa variable 3/OR2-268 (non-functional) (Fragment)362.907.76P04433Immunoglobulin kappa variable 3-111198.5426.09P01624Immunoglobulin kappa variable 3-15362.907.83A0A075B6H7Immunoglobulin kappa variable 3-7 (non-functional) (Fragment)362.907.76A0A0A0MRZ8Immunoglobulin kappa variable 3D-111198.5426.09A0A0C4DH55Immunoglobulin kappa variable 3D-7362.907.56P06312Immunoglobulin kappa variable 4-1250.9819.83P0CG04Immunoglobulin lambda constant 140610.5577.36P0DOY2Immunoglobulin lambda constant 244714.5193.40P0DOY3Immunoglobulin lambda constant 344714.5193.40P0CF74Immunoglobulin lambda constant 623147.6250.94A0M8Q6Immunoglobulin lambda constant 719435.3636.79P01715Immunoglobulin lambda variable 3-1344.5838.26B9A064Immunoglobulin lambda-like polypeptide 540610.5538.32Q9BQU0Inhibitory NK receptor242.6211.21Q9NVH2Integrator complex subunit 7267.394.26Q01638Interleukin-1 receptor-like 1304.247.01H0YNL8Iron-responsive element-binding protein 2377.9129.09A0A0G2JPA6Killer cell immunoglobulin-like receptor 3DL2242.6211.64P22079Lactoperoxidase2259.9135.11P02788Lactotransferrin862.7428.59A6NMS7Leucine-rich repeat-containing protein 37A263.121.71A6NM11Leucine-rich repeat-containing protein 37A2252.181.71O60309Leucine-rich repeat-containing protein 37A3276.064.53P31025Lipocalin-114925.9753.98Q86W92Liprin-beta-1292.7510.29P00338L-lactate dehydrogenase A chain196.5721.69Q9BY66Lysine-specific demethylase 5D307.108.58P61626Lysozyme C15283.5366.89P14174Macrophage migration inhibitory factor616.5647.83C9JF79Malate dehydrogenase (Fragment)263.7211.71P40925Malate dehydrogenase\_ cytoplasmic653.5511.38Q5HYA8Meckelin241.841.61Q9Y4B5Microtubule cross-linking factor 126.231.52Q8TAX7Mucin-713700.409.28U3KPS2Myeloblastin554.6917.67P24158Myeloblastin631.4328.52Q9NYA4Myotubularin-related protein 4315.447.11P59665Neutrophil defensin 11789.5225.53P59666Neutrophil defensin 31789.5225.53Q9BYH8NF-kappa-B inhibitor zeta371.154.32Q2L696Nucb2 splice variant663.9525.13A0A087WSV8Nucleobindin 2\_ isoform CRA_b954.6725.48P80303Nucleobindin-2954.6725.48P04746Pancreatic alpha-amylase88276.5955.97P42338Phosphatidylinositol 4_5-bisphosphate 3-kinase catalytic subunit beta isoform561.796.26A0A0A0MRF9Phosphoinositide phospholipase C313.904.55P13796Plastin-2283.9325.04Q86YL7Podoplanin866.9434.57P11940Polyadenylate-binding protein 1582.5910.69E7ERJ7Polyadenylate-binding protein582.5911.26Q8NDX5Polyhomeotic-like protein 3348.423.05P01833Polymeric immunoglobulin receptor12791.9357.98Q8TCS8Polyribonucleotide nucleotidyltransferase 1\_ mitochondrial32.493.19Q6S8J3POTE ankyrin domain family member E4118.4713.86A5A3E0POTE ankyrin domain family member F4040.7011.72P0CG38POTE ankyrin domain family member I3413.224.74P0CG39POTE ankyrin domain family member J2796.683.85Q8TED1Probable glutathione peroxidase 8341.4217.22Q8IZM9Probable sodium-coupled neutral amino acid transporter 6426.926.80K7EJ44Profilin470.7837.50P07737Profilin-1910.8249.29P12273Prolactin-inducible protein30448.2776.71A0A0A0MT31Proline-rich protein 423475.6872.29P07602Prosaposin510.4639.12Q5W0V3Protein FAM160B1862.8123.66Q6P5S2Protein LEG1 homolog6592.0936.97Q9H7Z3Protein NRDE2 homolog45.791.20P05109Protein S100-A83184.3023.66P06702Protein S100-A91737.5577.19O14795Protein unc-13 homolog B59.051.19H3BQ60Puratrophin-1 (Fragment)266.7950.00Q9BYX7Putative beta-actin-like protein 32063.1610.67Q5VSP4Putative lipocalin 1-like protein 13097.3111.11P52566Rho GDP-dissociation inhibitor 21026.8730.35P35913Rod cGMP-specific 3\'\_5\'-cyclic phosphodiesterase subunit beta374.148.08P02810Salivary acidic proline-rich phosphoprotein 1/24566.9172.29P02787Serotransferrin4566.9248.42P02768Serum albumin63281.6175.04O00193Small acidic protein258.6913.11P02808Statherin41653.648.39P02814Submaxillary gland androgen-regulated protein 3B20898.665.82Q9UH99SUN domain-containing protein 270.821.67A0A075B6V5T cell receptor alpha variable 36/delta variable 7 (Fragment)278.8924.78Q7Z6L1Tectonin beta-propeller repeat-containing protein 1384.237.12F2Z350Testis-expressed protein 29447.3732.14Q7Z4L5Tetratricopeptide repeat protein 21B78.574.56P20061Transcobalamin-1378.5122.86P29401Transketolase676.1030.98Q6ZMR5Transmembrane protease serine 11A281.1511.16P02766Transthyretin438.4644.22P60174Triosephosphate isomerase651.5636.36O43818U3 small nucleolar RNA-interacting protein 2297.8416.00A0A0J9YY99Uncharacterized protein (Fragment)242.4912.82H7C2Y3Uncharacterized protein C2orf80 (Fragment)318.8716.41H0Y8H3Uncharacterized protein C3orf67 (Fragment)590.5474.68A0A087WZY1Uncharacterized protein22581.816.60A0A0G2JMZ2Uncharacterized protein252.181.71A0A0G2JRT3Uncharacterized protein252.181.77P02774Vitamin D-binding protein245.2121.52Q14508WAP four-disulfide core domain protein 2935.9933.87Q9UDV6Zinc finger protein 212424.3916.97P25311Zinc-alpha-2-glycoprotein2292.6031.54Q96DA0Zymogen granule protein 16 homolog B46355.0958.17

Table 4Proteins of the saliva identified in only in the individual analysisAccession numberProtein namescoreCover(%)P3194714-3-3 protein sigma297.1724.60O0023126S proteasome non-ATPase regulatory subunit 11453.0710.66P68032Actin\_ alpha cardiac muscle 17799.8426.53P68133Actin\_ alpha skeletal muscle7799.8426.53P62736Actin\_ aortic smooth muscle7555.9523.61P60709Actin\_ cytoplasmic 117763.8465.60P63261Actin\_ cytoplasmic 217763.8465.60P63267Actin\_ gamma-enteric smooth muscle7555.9523.67Q0VD77ADAMTS-like protein 5410.0032.06P00813Adenosine deaminase350.6712.67O60503Adenylate cyclase type 9471.535.69Q99996A-kinase anchor protein 934.163.58C9JKR2Albumin\_ isoform CRA_k29220.4874.82P01009Alpha-1-antitrypsin413.6711.24P01023Alpha-2-macroglobulin445.7115.33A8K2U0Alpha-2-macroglobulin-like protein 1148.5110.32P04745Alpha-amylase 197076.2478.86P19961Alpha-amylase 2B77429.3262.82P06733Alpha-enolase1439.5949.08Q8N6M6Aminopeptidase O261.5810.13Q01484Ankyrin-239.244.22P02652Apolipoprotein A-II941.6447.00Q14562ATP-dependent RNA helicase DHX8365.217.38Q8IYB8ATP-dependent RNA helicase SUPV3L1\_ mitochondrial331.227.00P04280Basic salivary proline-rich protein 18867.9744.39P02812Basic salivary proline-rich protein 254196.7769.71I3L192Basigin (Fragment)185.7016.88P61769Beta-2-microglobulin2754.0754.62Q562R1Beta-actin-like protein 21943.0510.90P13929Beta-enolase131.587.60O95342Bile salt export pump495.588.18Q96DR5BPI fold-containing family A member 26426.1643.37Q8N4F0BPI fold-containing family B member 26613.0037.99Q9NQY0Bridging integrator 3398.0311.46Q8N4G4CA6 protein294.754.47O75808Calpain-15215.663.68P23280Carbonic anhydrase 69824.0457.47Q0P665CCDC88C protein188.410.00Q8N163Cell cycle and apoptosis regulator protein 2573.4911.05O14647Chromodomain-helicase-DNA-binding protein 2250.162.84H0Y7A8Chromosome 9 open reading frame 3 (Fragment)236.1819.31P35606Coatomer subunit beta\'189.712.21A2ABG0Complement C2 (Fragment)409.3820.25P01024Complement C3526.6824.53Q53SF7Cordon-bleu protein-like 1168.784.32P04080Cystatin-B1041.4270.41P01034Cystatin-C3437.7651.37P28325Cystatin-D2141.1675.35P01036Cystatin-S28189.6376.60P09228Cystatin-SA13641.1967.38P01037Cystatin-SN28293.3170.21P54108Cysteine-rich secretory protein 3373.1134.29Q8NF50Dedicator of cytokinesis protein 8351.745.72Q9UGM3Deleted in malignant brain tumors 1 protein285.957.05Q5TBH6Dihydroxyacetone phosphate acyltransferase (Fragment)182.7823.42P28340DNA polymerase delta catalytic subunit269.075.15M0R2B7DNA polymerase269.075.03Q5T4S7E3 ubiquitin-protein ligase UBR422.832.70Q92838Ectodysplasin-A258.6415.86Q8N3D4EH domain-binding protein 1-like protein 1260.454.33Q6P179Endoplasmic reticulum aminopeptidase 2522.887.92Q7L775EPM2A-interacting protein 1277.972.80Q9H501ESF1 homolog205.3012.22A0A1B0GUN9Espin59.796.02Q8IXL6Extracellular serine/threonine protein kinase FAM20C322.365.48Q01469Fatty acid-binding protein\_ epidermal444.2032.59Q9BZK7F-box-like/WD repeat-containing protein TBL1XR1376.5715.18P02675Fibrinogen beta chain187.4413.03P15328Folate receptor alpha400.3835.80Q8NHY3GAS2-like protein 2287.316.14P06396Gelsolin427.9917.77O14893Gem-associated protein 2443.1431.07P53611Geranylgeranyl transferase type-2 subunit beta470.8516.92P06744Glucose-6-phosphate isomerase787.2628.49P04406Glyceraldehyde-3-phosphate dehydrogenase793.8639.40O95427GPI ethanolamine phosphate transferase 1233.927.73Q8IWJ2GRIP and coiled-coil domain-containing protein 222.311.25P00738Haptoglobin1233.1155.42P00739Haptoglobin-related protein281.2815.52G3V1N2HCG1745306\_ isoform CRA_a15851.3694.55E7BWR8HCG2043595\_ isoform CRA_a252.747.76P69905Hemoglobin subunit alpha16443.6283.80P68871Hemoglobin subunit beta22740.6595.24P02042Hemoglobin subunit delta5150.5839.46P02100Hemoglobin subunit epsilon2097.616.80P69891Hemoglobin subunit gamma-12097.616.80P69892Hemoglobin subunit gamma-22097.616.80P15515Histatin-15208.4136.84P15516Histatin-34795.6613.73E9PRF4Histone-lysine N-methyltransferase (Fragment)316.723.89Q15047Histone-lysine N-methyltransferase SETDB1316.723.80P47902Homeobox protein CDX-1196.3826.04P31270Homeobox protein Hox-A11264.9114.38P09630Homeobox protein Hox-C693.474.68Q4G0P3Hydrocephalus-inducing protein homolog264.632.46A0A0G2JMB2Ig alpha-2 chain C region (Fragment)48303.2779.12A0A0A0MS07Ig gamma-1 chain C region (Fragment)3209.8645.76A0A087WYJ9Ig mu chain C region3019.3654.87P04220Ig mu heavy chain disease protein2170.3639.90P01876Immunoglobulin heavy constant alpha 140927.7284.42P01877Immunoglobulin heavy constant alpha 228394.9268.53P01857Immunoglobulin heavy constant gamma 15891.8250.91P01859Immunoglobulin heavy constant gamma 21360.1031.29P01860Immunoglobulin heavy constant gamma 31756.6130.24P01861Immunoglobulin heavy constant gamma 41509.9230.89P01871Immunoglobulin heavy constant mu3019.3654.75A0A075B7D0Immunoglobulin heavy variable 1/OR15-1 (non-functional) (Fragment)252.2810.26A0A075B7F0Immunoglobulin heavy variable 3/OR16-10 (non-functional) (Fragment)3426.8113.79S4R460Immunoglobulin heavy variable 3/OR16-9 (non-functional)8502.5136.46P01762Immunoglobulin heavy variable 3-113426.8123.08P01766Immunoglobulin heavy variable 3-133426.8113.79A0A0C4DH32Immunoglobulin heavy variable 3-20 (Fragment)3426.8113.68A0A0B4J1V1Immunoglobulin heavy variable 3-213426.8123.08A0A0B4J1X8Immunoglobulin heavy variable 3-433426.8113.56P01763Immunoglobulin heavy variable 3-483426.8123.08P01780Immunoglobulin heavy variable 3-73426.8123.08P01782Immunoglobulin heavy variable 3-93426.8113.56A0A0B4J1U7Immunoglobulin heavy variable 6-1294.245.79P01591Immunoglobulin J chain21280.2568.55P01834Immunoglobulin kappa constant37053.2185.98P04433Immunoglobulin kappa variable 3-111303.4826.09P01619Immunoglobulin kappa variable 3-20868.067.76A0A0A0MRZ8Immunoglobulin kappa variable 3D-111303.4826.09P06312Immunoglobulin kappa variable 4-1423.9219.83P0CG04Immunoglobulin lambda constant 133910.9077.36P0DOY2Immunoglobulin lambda constant 240674.0777.36P0DOY3Immunoglobulin lambda constant 340674.0777.36P0CF74Immunoglobulin lambda constant 630147.4050.94A0M8Q6Immunoglobulin lambda constant 722557.5736.79B9A064Immunoglobulin lambda-like polypeptide 533910.938.32P06870Kallikrein-1196.2010.31P43626Killer cell immunoglobulin-like receptor 2DL1252.747.76A0A0G2JNJ6Killer cell immunoglobulin-like receptor 2DS1325.7616.62Q9HAQ2Kinesin-like protein KIF9158.594.43B4DZK5Kinesin-like protein133.3710.51Q6H2H3KIR2DL1252.747.76P22079Lactoperoxidase1577.0341.43P02788Lactotransferrin1069.9935.21Q6PKG0La-related protein 1139.166.20P09960Leukotriene A-4 hydrolase225.5519.31P31025Lipocalin-18361.3651.14P00338L-lactate dehydrogenase A chain986.5220.78Q9BYZ2L-lactate dehydrogenase A-like 6B323.868.66Q9BY66Lysine-specific demethylase 5D59.780.78P61626Lysozyme C9288.5654.05P14174Macrophage migration inhibitory factor254.1855.65P14780Matrix metalloproteinase-9225.6215.13Q96JG8Melanoma-associated antigen D4150.966.07P01033Metalloproteinase inhibitor 1445.2529.95Q96GX9Methylthioribulose-1-phosphate dehydratase198.9923.14O15021Microtubule-associated serine/threonine-protein kinase 4168.043.43O43283Mitogen-activated protein kinase kinase kinase 13533.358.70Q8TAX7Mucin-710429.0115.65Q8NI22Multiple coagulation factor deficiency protein 2260.4323.97O75970Multiple PDZ domain protein43.132.32P24158Myeloblastin341.2317.19P59665Neutrophil defensin 12353.0415.96P59666Neutrophil defensin 32353.0415.96P04746Pancreatic alpha-amylase64829.7760.27Q08752Peptidyl-prolyl cis-trans isomerase D470.0817.57P13796Plastin-2531.4128.87P01833Polymeric immunoglobulin receptor16305.4245.42Q6S8J3POTE ankyrin domain family member E3659.079.49A5A3E0POTE ankyrin domain family member F3575.1010.14P0CG38POTE ankyrin domain family member I2591.405.67P0CG39POTE ankyrin domain family member J1362.794.82P17844Probable ATP-dependent RNA helicase DDX5220.364.89I3L3D5Profilin (Fragment)1209.8110.91P07737Profilin-11209.8120.71P12273Prolactin-inducible protein22984.4189.04A0A0A0MT31Proline-rich protein 452615.6972.29P07602Prosaposin316.9222.52Q9P219Protein Daple206.070.69P49354Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha1184.1517.41Q6P5S2Protein LEG1 homolog7928.1940.00Q9H7Z3Protein NRDE2 homolog339.416.79Q8WYL5Protein phosphatase Slingshot homolog 1286.922.38O43663Protein regulator of cytokinesis 183.557.42P05109Protein S100-A81391.4631.18P06702Protein S100-A92043.0078.07Q9NQW1Protein transport protein Sec31B442.027.63Q92954Proteoglycan 4188.502.78Q96MK3Pseudokinase FAM20A287.958.50Q9BYX7Putative beta-actin-like protein 31353.8729.07Q5VSP4Putative lipocalin 1-like protein 13095.8011.11Q5JXB2Putative ubiquitin-conjugating enzyme E2 N-like341.7032.03A4QN01Putative uncharacterized protein encoded by LINC01553191.0219.53Q15276Rab GTPase-binding effector protein 1211.798.58Q9Y2J0Rabphilin-3A47.857.93Q14699Raftlin796.0517.30G3XAJ6Raft-linking protein\_ isoform CRA_c779.8113.84P52565Rho GDP-dissociation inhibitor 1251.7219.61Q8IXT5RNA-binding protein 12B263.796.39K4DI92RWD domain containing 4A636.7530.48Q6NW29RWD domain-containing protein 4636.7530.32P02810Salivary acidic proline-rich phosphoprotein 1/252615.6972.29Q9BZL6Serine/threonine-protein kinase D2403.289.68B4DTS2Serine/threonine-protein kinase401.269.57P02787Serotransferrin4390.4139.26P02768Serum albumin64055.3579.80P02808Statherin25654.5448.39P02814Submaxillary gland androgen-regulated protein 3B50678.1165.82P00441Superoxide dismutase \[Cu-Zn\]1005.4745.45H0YN01Talin-2197.3034.55Q92609TBC1 domain family member 5344.395.16Q7Z6L1Tectonin beta-propeller repeat-containing protein 162.512.49Q6N022Teneurin-464.414.15P10599Thioredoxin300.3632.38Q96J01THO complex subunit 3335.4620.51Q5JTD0Tight junction-associated protein 1432.543.95P37837Transaldolase676.7023.74P20061Transcobalamin-1670.4933.26A6H8Y1Transcription factor TFIIIB component B\'\' homolog67.016.17P29401Transketolase1109.1829.05Q9C0B7Transport and Golgi organization protein 6 homolog101.098.78P60174Triosephosphate isomerase582.0715.73P07437Tubulin beta chain251.865.86Q13885Tubulin beta-2A chain268.915.84Q9BVA1Tubulin beta-2B chain251.865.84P04350Tubulin beta-4A chain242.625.86P68371Tubulin beta-4B chain242.625.84H3BLT7Tubulin monoglycylase TTLL3 (Fragment)205.551.15Q9NVE5Ubiquitin carboxyl-terminal hydrolase 4049.556.15Q70EL2Ubiquitin carboxyl-terminal hydrolase 45709.8412.04D6RC01Ubiquitinyl hydrolase 1685.2010.14B4DSH7UDP-galactose translocator296.2722.16H7C2Y3Uncharacterized protein C2orf80 (Fragment)203.0550.78Q9H1L0Uncharacterized protein MIR1-1HG440.6132.48A0A087WZY1Uncharacterized protein50162.8616.60J3QRI8UPF0183 protein C16orf70 (Fragment)350.1332.65Q13488V-type proton ATPase 116 kDa subunit a isoform 3105.999.40Q14508WAP four-disulfide core domain protein 22122.2633.87Q9NXC5WD repeat-containing protein mio208.071.94Q9BUG6Zinc finger and SCAN domain-containing protein 5A97.4113.71Q8N8U3Zinc finger CCHC domain-containing protein 5189.027.79Q9H0M4Zinc finger CW-type PWWP domain protein 1242.577.10Q9NWS9Zinc finger protein 44677.757.56P25311Zinc-alpha-2-glycoprotein1420.8028.19Q96DA0Zymogen granule protein 16 homolog B32673.1156.73

Discussion
==========

This study aimed at standardizing a protocol for proteomic analysis of saliva that is sensitive, easy to perform and of low cost, to be used in future experiments involving quantitative shotgun proteomics. The first issue to be solved was related to the necessity of depletion of highly abundant proteins in saliva, such as albumin and IgG[@B8] ^,^ [@B14] that could mask and make difficult the identification of low abundance biomarkers. Krief and collaborators[@B7] (2011) evaluated whether depletion of salivary amylase, albumin and IgGs could improve the ability to visualize proteins in two-dimensional gel electrophoresis (2-DE) in oral fluids. They observed 36 new spots after depletion, and 58 spots showed more than twofold increase intensity after depletion[@B7]. Therefore, we hypothesized that this better identification profile could occur not only in two-dimensional gel electrophoresis (2-DE), but also in shotgun proteomics, when albumin and IgG were depleted. Thus, in the first test, we compared the use or not of the albumin and IgG depletion column after the extraction process of the salivary proteins. For this, we used a pool of ten saliva samples. When the column was used, only 35 proteins were identified ([Table 1](#t1){ref-type="table"}). This figure increased to 248 when the column was not used ([Table 2](#t2){ref-type="table"}). We believe this occurred because, when using the albumin and IgG depletion column, there was also depletion of other proteins, since using the column increases one more process in the methodology. We also believe that many proteins could bind to albumin and IgGs, thus being depleted together. Among the identified proteins, in both situations, are those typically found in saliva. By contrast, when the depletion column was used, classical salivary proteins such as 14-3-3 proteins, histatins, statherin, lactoperoxidase, lactotransferrin, lysozyme C, neutrophil defensins, protein S100A9, serotransferrin and some cystatin isoforms were not identified. Thus, contrary to what was observed in gel-based proteomics[@B7], in shotgun proteomics the use of albumin and IgG depletion column impaired protein identification according to our workflow. Some studies, in spite of that, report advantages in using depletion columns when more than one workflow is employed[@B14]. However, this increases the time and cost of the analysis.

In the second test, we compared analysis of pooled samples (from ten individuals) *versus* individual analysis, without using the depletion column. In the individual analysis 239 proteins were identified ([Table 4](#t4){ref-type="table"}), while 212 proteins were identified in the pooled sample ([Table 3](#t3){ref-type="table"}). One-hundred and twenty three proteins were common to both groups (data not shown), and among them are most of the proteins typically found in saliva. The proteins exclusively found in the individual sample or in the pooled sample are not typically reported in saliva, which might be related to individual variation. The analysis of individual samples is important to allow confident comparison among the groups under study, especially in quantitative shotgun proteomics.

Generally, the methodologies used in proteomics are classified into two main categories: the bottom-up, which is also called shotgun proteomics, or top-down proteomics. Both methodologies have advantages and limitations, and their employment depends on the treatment given to the sample[@B9]. Shotgun proteomics is characterized by analyzing samples after proteolytic digestion in peptides, which is typically performed with trypsin[@B2] ^,^ [@B9], while the top-down proteome of a sample involves analysis of intact proteins[@B9]. In shotgun proteomics, proteins from a complex mixture are digested, and the resulting peptides are analyzed by mass spectrometry. One of the advantages of this strategy is to investigate a large number of proteins regardless of their size. The limitations are related to incomplete coverage of the protein sequence, loss of post-translational modifications and degradation because of proteolytic digestion[@B4] ^,^ [@B9]. The top-down proteomics differs from the shotgun as it explores intact proteins by injecting the proteins into the mass spectrometer without performing digestion, minimizing any change in the sample and allowing a better characterization of post-translational modifications, especially those related to naturally occurring cleavages and alternative splicing[@B3], avoiding interference problems based on peptides and allowing deducing the primary structure of the protein[@B4] ^,^ [@B9]. However, this technique is considered bounded by the collision energy required in protein fragmentation, which is insufficient for proteins greater than 50 KDa, and its application is restricted to the analysis of purified proteins[@B4] ^,^ [@B9] ^,^ [@B11]. In addition, top-down proteomics method requires the use of one or more forms of separation prior to mass spectrometry analysis[@B12]. Moreover, top-down platforms are intrinsically limited by the sample treatments required for use in mass spectrometry, involving the use of acids such as formic and trifluoroacetic acid[@B9] ^,^ [@B12] ^,^ [@B19], which inevitably exclude proteins that are insoluble in acidic solutions. In addition, intact high molecular weight proteins and heterogeneous glycosylated proteins are not accessible in their naturally occurring form, even to the best level of mass spectrometry[@B2].

Previous studies demonstrated that top-down platforms cannot achieve the same coverage of shotgun platforms for different reasons, such as: i) the intact protein must be soluble in the acid solution compatible with an ESI-MS analysis; (ii) the protein should not be heterogeneous (glycosylated isoforms), because in this case the intact protein mass cannot be deduced by the ESI spectrum; (iii) protein dimensions have to be limited, because MS-MS fragmentation spectra are too complex to be interpreted[@B3] ^,^ [@B15]. Nonetheless, the top-down strategy may reveal the richness of the isoform and the diversity of post-translational modifications, which in the shotgun proteomics strategy may result in the relevant loss of this molecular information[@B2] ^,^ [@B3]. Thus, shotgun proteomics may exhibit this deficiency in the human saliva proteome, in which many proteins such as basic PRPs and acids are not very susceptible to the proteolytic enzymes action and reveal very similar sequences. Therefore, many fragments cannot be related to a specific original protein. However, the shotgun platforms showed the best performance in terms of number of components detected, because the sensitivity of mass spectrometry is sufficient to reveal thousands of peptides in a single analysis. In this way, shotgun proteomics covers the largest variety of detectable components, regardless of their mass, due to the proteolytic digestion of large proteins almost always generates peptides that can disclose the presence of the protein in a complex mixture. Due to these reasons, the number of salivary components currently detectable by shotgun proteomics approaches is more than five times greater than that of components detected by any other platform[@B2] ^,^ [@B10]. Thus, in this study we employed shotgun proteomics.

Based on the results of the two tests, the protocol for salivary shotgun proteomic analysis was satisfactory, since it allowed the identification of many proteins, including those typically found in saliva. Moreover, it is easy to perform and cheaper than the methods previously described, since it does not require the use of depletion columns. Furthermore, it allows individual analysis of the samples, which is very important in quantitative proteomics. Thus, this protocol could be used in future studies involving shotgun proteomic analysis of saliva.
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[^1]: Standardization of a protocol for shotgun proteomic analysis of saliva
